What is the warranty period for the analyzer?

The specific warranty period is not mentioned in the product description.

Clinical Diagnostic Fully Automated Blood Chemistry Analyzer Biochemistry Analyzer Ds-261

Name: Clinical Diagnostic Fully Automated Blood Chemistry Analyzer Biochemistry Analyzer Ds-261
Brand: SINNOWA Medical Science & Technology Co., Ltd.
SKU: 906415675

Jiangsu, ChinaSINNOWA Medical Science & Technology Co., Ltd.

US$3,600.00-4,200.00

1 UNIT

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Biochemistry Analyzer

Model NO.

DS-261

Certification

CE, EEC, MSDS, ISO13485

Transport Package

Carton

Specification

CARTON DIMENSION: 106x89x77CM; G. W.: 133KG

Trademark

SINNOWA or OEM

Origin

China

HS Code

9027500090

Production Capacity

100units/Month

Key features

Comprehensive Certification: CE, EEC, MSDS, ISO13485 certified for global market compliance.

Global Service Network: Clients in 80+ countries with online service and training support.

OEM/ODM Capability: Custom manufacturing services available for specific requirements.

GMP Standard Production: Manufactured in GMP standard workshops with multiple production lines.

Fast Lead Time: Average lead time within 15 workdays for both peak and off seasons.

Experienced Manufacturer: Established in 2002 with 20 R&D engineers and 215 employees.

Company profile

SINNOWA Medical Science & Technology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2002-10-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤15h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummarySINNOWA Medical Science & Technology Co., Ltd. is a China-based medical manufacturing company established in 2002, with 215 employees and a 66,000 m² manufacturing plant. It produces in vitro diagnostic equipment and related reagents, including automatic electrolyte analyzer standard solutions. The supplier reports ISO 9001:2015 certification and compliance with ISO 13485 and ISO 9001, while CE certification is stated and FDA certification is in progress. Its R&D organization includes more than 70 specialists and engineers, and it operates five production lines with 11–20 quality-control staff. The supplier reports exports to multiple regions, products sold in more than 80 countries through distributors and OEM partners, and order lead times within 15 working days in both peak and off-peak periods. Evidence is insufficient to assess financial credibility and customization capability directly.

Supplier typeThe supplier is identified as SINNOWA Medical Science & Technology Co., Ltd., a Chinese limited company and factory based in Jiangsu. Its stated business is manufacturing in vitro diagnostic equipment and related reagents, including chemistry and electrolyte analyzers.

CertificationsThe supplier reports ISO 9001:2015 certification and states that its diagnostic products comply with ISO 13485 and ISO 9001. It also states that all products are CE certified, while FDA certification is still in progress, so certification coverage is positive but not complete for FDA requirements.

R&D capabilitySINNOWA reports an R&D team of more than 70 specialists and engineers, with 50% holding master’s degrees, and 20 years of R&D engineer experience. Its product range covers multiple in vitro diagnostic categories, supporting a positive assessment of technical development capacity.

Production capacityThe supplier reports 215 employees, five production lines, a 66,000 m² manufacturing plant, and 11–20 quality-control staff. It also states that peak- and off-peak-season order fulfillment is within 15 working days, indicating established manufacturing and delivery capacity.

Client casesThe supplier states that its products have been sold in more than 80 countries through distributors and OEM cooperators, and reports export activity beginning in 2002 with multiple international markets served. These statements provide direct evidence of broad international customer and channel experience.